Does SIGLEC8 localize to the subcellular compartment like the Alzheimer's disease protective CD33 splice variant?

Does SIGLEC8 localize to the subcellular compartment like the Alzheimer's disease protective CD33 splice variant?

Bibliographic Details
Main Author:	Chirag Dhar
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	SIGLEC Alzheheimer's disease CD33 SIGLEC8 sialic acid
Online Access:	https://www.frontiersin.org/articles/10.3389/fncel.2023.1124150/full

Similar Items

Siglecs as Therapeutic Targets in Cancer
by: Jackwee Lim, et al.
Published: (2021-11-01)

CD33 as a leukocyte-associated marker expressed on human spermatozoa
by: Nasrin Sereshki, et al.
Published: (2023-04-01)

Current Status on Therapeutic Molecules Targeting Siglec Receptors
by: María Pia Lenza, et al.
Published: (2020-12-01)

Phosphoproteomics identifies microglial Siglec‐F inflammatory response during neurodegeneration
by: Nader Morshed, et al.
Published: (2020-12-01)

B Cell Siglecs–News on Signaling and Its Interplay With Ligand Binding
by: Sarah J. Meyer, et al.
Published: (2018-12-01)

Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding Proteins
by: Jeremy A. O’Sullivan, et al.
Published: (2017-08-01)

Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments
by: Elena Gianchecchi, et al.
Published: (2021-05-01)

Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases
by: Jannis Wißfeld, et al.
Published: (2024-03-01)

Sialic Acid-Siglec-E Interactions During Pseudomonas aeruginosa Infection of Macrophages Interferes With Phagosome Maturation by Altering Intracellular Calcium Concentrations
by: Kaustuv Mukherjee, et al.
Published: (2020-02-01)

Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation
by: Yaw-Wen Hsu, et al.
Published: (2021-01-01)

Expression of a Siglec-Fc Protein and Its Characterization
by: Kaijun Chi, et al.
Published: (2023-04-01)

Siglec Signaling in the Tumor Microenvironment
by: Eline J. H. van Houtum, et al.
Published: (2021-12-01)

Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer
by: John Daly, et al.
Published: (2019-05-01)

SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity
by: Panagiota Bouti, et al.
Published: (2023-12-01)

Functions and therapeutic targets of Siglec-mediated infections, inflammations and cancers
by: Chia-Hsueh Lin, et al.
Published: (2021-01-01)

First Evidence for a Role of Siglec-8 in Breast Cancer
by: Anna Trebo, et al.
Published: (2021-02-01)

Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
by: Yingyan Yu, et al.
Published: (2023-05-01)

Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases
by: Takashi Angata
Published: (2020-01-01)

Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis
by: Yan Zhuang, et al.
Published: (2022-11-01)

Investigating Association of Human-Specific Derived Alleles of CD33 and Other Genes with Lifespan of Iranians
by: Mehdi Kargar, et al.
Published: (2019-09-01)

Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cells
by: Yun Cao, et al.
Published: (2023-10-01)

Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs
by: Takashi Angata
Published: (2018-12-01)

Sialic Acid-Siglec Axis as Molecular Checkpoints Targeting of Immune System: Smart Players in Pathology and Conventional Therapy
by: Przemyslaw Wielgat, et al.
Published: (2020-06-01)

Analysis of Genetic Variants Associated with Levels of Immune Modulating Proteins for Impact on Alzheimer’s Disease Risk Reveal a Potential Role for SIGLEC14
by: Benjamin C. Shaw, et al.
Published: (2021-06-01)

Sialic Acids and Their Influence on Human NK Cell Function
by: Philip Rosenstock, et al.
Published: (2021-01-01)

Sequence variety in the CC’ loop of Siglec-8/9/3 determines the recognitions to sulfated oligosaccharides
by: Yucheng Wang, et al.
Published: (2023-01-01)

Inhibitory Siglec-sialic acid interactions in balancing immunological activation and tolerance during viral infections
by: Pratima Saini, et al.
Published: (2022-12-01)

The intriguing roles of Siglec family members in the tumor microenvironment
by: Kui-Ying Jiang, et al.
Published: (2022-04-01)

Targeting CD24 in Cancer Immunotherapy
by: Wenwen Chen, et al.
Published: (2023-11-01)

Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease
by: Silva Herzog, et al.
Published: (2022-09-01)

CD24: A Novel Target for Cancer Immunotherapy
by: Emmanouil Panagiotou, et al.
Published: (2022-07-01)

Control of Innate Immunity by Sialic Acids in the Nervous Tissue
by: Huan Liao, et al.
Published: (2020-07-01)

The Role of Sialic Acids in the Establishment of Infections by Pathogens, With Special Focus on Leishmania
by: Tainá Cavalcante, et al.
Published: (2021-05-01)

Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis
by: Intan M.W. Dewi, et al.
Published: (2021-05-01)

Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10
by: Shan-Shan Yin, et al.
Published: (2020-07-01)

Novel Siglec-15-Sia axis inhibitor leads to colorectal cancer cell death by targeting miR-6715b-3p and oncogenes
by: Mohammed Saqif Ahmad, et al.
Published: (2023-10-01)

Potential Targeting of Siglecs, Mast Cell Inhibitory Receptors, in Interstitial Cystitis
by: Chang-Shin Park, et al.
Published: (2011-06-01)

Siglec-1 Expressed on Dendritic Cells is a New Receptor Implicated in Arenavirus Uptake
by: Xabier Muniz-Trabudua, et al.
Published: (2020-06-01)

Siglecs in Brain Function and Neurological Disorders
by: Shoib Sarwar Siddiqui, et al.
Published: (2019-09-01)

The Paired Siglecs in Brain Tumours Therapy: The Immunomodulatory Effect of Dexamethasone and Temozolomide in Human Glioma In Vitro Model
by: Przemyslaw Wielgat, et al.
Published: (2021-02-01)